The Vall d’Hebron Institute of Research’s Paediatric Cancer and Hematological Diseases Research Group Achieves Promising Results for Acute Graft-Versus-Host Disease.

This project of personalized and regenerative medicine will carry out the first clinical trial in Spain to treat burns and skin wounds with bioprinted autologous human skin substitutes.

This recognition highlights both his career and the level of respiratory research in Spain.

The Neonatology Service aims to demonstrate that the individual family room for newborns is more beneficial than the shared box room.

The ERS Awards recognize outstanding members for their exceptional contributions in the field of respiratory medicine.

The awarded study is titled “Perceptions and experiences of parents of premature newborns with an umbilical venous catheter who perform skin-to-skin contact,” and the granted scholarship will allow for its dissemination.

The Multidisciplinary Cancer Committee has evaluated a total of 701 patients since its creation.

The study aims to investigate how excess body fat alters the number and function of T lymphocytes, leading to a greater predisposition to infectious diseases.

The head of the Diagnostic Nanotools (DINA) group was part of a Spanish delegation that also participated in activities to establish contracts between national and international centers.

Two international studies led by Vall d'Hebron recommend early administration of specific drugs to prevent migraine to achieve a better response to therapy.

Irritability in ADHD and BDP is an understudied symptom that has a major impact on patients' quality of life and may even increase the risk of suicide.

Around 150 people participated in a day filled with conferences, presentations, and networking activities.

A study from the Vall d’Hebron Campus demonstrates that the Ex Vivo C5b-9 deposition test is useful for monitoring the activity of the complement system (CS) in patients with aHUS or transplant-associated TMA.

The report includes the centre's scientific and institutional highlights for 2023.

The Evaluation Commission of health research institutes of the Instituto de Salud Carlos III has unanimously renewed the accreditation of the Vall d’Hebron University Hospital Research Institute (IR-HUVH).

Dr. Elizabeth Echoka proposes a digital platform to monitor obstetric risks in pregnant women in underserved populations.

The device, called Winco USG, is a simulation platform for holistic and integrated training of professionals performing this type of procedure.

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

So far, 240 volunteers have been recruited within all the centres set to join adolescents’ clinical trial (named HH3) to test the efficacy, tolerability, and safety of the BIMERVAX® COVID-19 vaccine in adolescents aged 12 to 17.

"Patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis present miRNA profiles in urinary extracellular vesicles associated with disease progression" was the awarded work.

The study, which provides guidelines for the clinical management of these patients, reveals that only children with a recent stem cell transplant or with other additional diseases have a higher risk of complications from COVID-19.

This project will make societies aware of their rights related to sexual and reproductive health and empower young people to make informed and appropriate choices.

Dr. Miravitlles’ career was recognized during the 57th edition of the SEPAR National Congress held in Valencia.

The team will investigate, in animal models, the benefits of histotripsy, a technique that allows tumors to be destroyed without incision or heat, and hopes to minimize the risks and enhance the efficacy of immunotherapy.